Pharmaceutical live biotherapeutics plant

Saint-Simon’s plant owns internationally recognized accreditations and licenses aiming for excellence and customers’ trust.

One of Lallemand Health Solutions probiotic manufacturing plant is in Saint-Simon, a commune situated in the Aurillac Basin in the Cantal department in south-central France. In the Saint-Simon installation are produced probiotic supplements for the pharmaceutical and nutraceutical industries as well as ferments for the agri-food industries. The Saint-Simon plant has earned internationally recognized accreditations and licenses throughout the years and is fully certified to produce probiotics (pure strains), live biotherapeutics (active pharmaceutical ingredients – API) and investigational products.  

A Unique Global Probiotic Partner, Vertically Integrated from Lab to Shelf

Vertically integrated from lab to shelf, all the probiotic production steps are done in-house in this cutting-edge plant, from pilot-scale fermentation to final packaging in sticks or sachets. Our process and quality controls teams ensure the excellence of our products.

Key milestones

  • In 1988, Lallemand acquires a bacterial Pharma GMP production plant located in Saint-Simon, France, authorized to produce human medicinal products. 
  • In 2021, to all production licenses and certifications acquired to date, Saint-Simon plant extends its pharma manufacturer’s authorization to human investigational medicinal products. 

Key facts

  • 80+ million sachets per year
  • 130+ employees
  • 75+ years of know-how
  • €20M+ continuous investments in the last 7 years and more investments and developments to come
Major investments of several million euros are planned over the coming years in order to continue to increase our production capacities, develop our expertise and consolidate our expansion in a growing market.”

Thanks to

  • Dedicated employees
  • Production know-how
  • State-of-the-art technologies
  • Adherence to the highest quality standards of the industry

Probiotic Manufacturing Process

We invite you inside the walls of Lallemand Health Solutions’ French plant located in Saint-Simon, to see how probiotic supplements are produced for the pharmaceutical and nutraceutical industries.


On the occasion of the 21st alternating meeting of the Prime Ministers of Quebec, François Legault, and France, Gabriel Attal, Lallemand announced an investment of $30 million, over five years, for the production of live biotherapeutics and probiotics at its Saint-Simon (Cantal) plant. Read More